ATOS has been a quiet performer in my portfolio so far. Had positive news recently with the Phase 2 study of Endoxifen as well as it's inclusion in the Russell 2000 and 3000 indexes.
I'm hoping to see further strength in it's performance in the future.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
